CI Capital managing pharma company listing on the EGX, European listing, alongside other projects this year

CI Capital has a number of transactions in its pipeline in sectors including tourism, real estate, manufacturing, and pharma, Managing Director Tarek Tantawy said yesterday. The company expects to complete the listing of a pharma manufacturer on the EGX in 3Q2018, according to Tantawy, who didn’t disclose the name. CI Capital is also participating with other international investment banks in the listing of an unnamed European company on a European stock exchange, he added without elaborating.